Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Still entirely a mouse result
Human clinical trial data remains sparse, and the compound shares much of BPC-157's regulatory history: popular before 2023, restricted under Biden-era FDA action, and now under consideration for reinstatement
Human medical use remains uncertain because BPC-157 lacks FDA approval, standardized dosing, and strong controlled clinical evidence
Large-scale clinical studies in humans are still required to confirm their safety, efficacy, and potential therapeutic value
Annual Review of Physiology, 37, 379-408
These injections typically contain cyanocobalamin or hydroxocobalamin, two commonly used synthetic forms of vitamin B12
US$ 20.52
US$ 27.08
US$ 27.71
US$ 20.37
US$ 27.19
US$ 20.45
